• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Resilience Acquires Ology Bioservices

    RDIF, Hualan Ink COVID-19 Vaccine Deal

    Kintor, Visum Enter COVID-19 Manufacturing Partnership

    Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU

    Evotec Enters Master Service Agreement with Kazia Therapeutics
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Resilience Acquires Ology Bioservices

    RDIF, Hualan Ink COVID-19 Vaccine Deal

    Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU

    Evotec Enters Master Service Agreement with Kazia Therapeutics

    Bristol Myers Squibb Expands at Cambridge Crossing
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Emergent BioSolutions

    Almac Group

    Reed-Lane

    Syngene

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Aphena Pharma Solutions

    Syngene

    PCI Pharma Services

    Quotient Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Biomanufacturing Trends and Outlook 2017: Where Is It All Going?

    A look at the technological advances permeating (bio)pharma manufacturing

    Related CONTENT
    • Ensuring Pharma Manufacturing Quality
    • RBQM Comes of Age: COVID as a Catalyst for Change
    • Advanced Analytics Advancing Development of Genetic Vaccines
    • Outsourcing Solid Dosage Manufacturing
    • Reshaping the Pharmaceutical Supply Chain
    Ben Locwin, Contributing Editor04.20.17
    Compared with just two years ago, biomanufacturing continues to advance and evolve. For example, according to BioPlan Associates’ 2015 annual report, more than 90% of facilities were using single use/disposable technologies, and planning and future modeling was designed to balance out the various costs and risks associated with disposable vs. stainless steel technologies for the long term.

    Is technology the end-all?
    Currently, more than 9 out of 10 contract manufacturing organizations (CMOs) are using disposables, and they are continuing to see benefits, though they are also reporting some dissatisfaction with the offerings and future trajectory of the disposables market.

    Oftentimes, technology is erroneously considered a proxy for the hard work and activities in the industry. It’s easy to point to something like wearable tech, social media platforms, single-use disposables and hold that as a mental heuristic for the cause of pharma industry improvements. But as the saying goes, “The map is not the territory,” and just because process improvements are happening concurrently and coincidentally with the use of disposables and other technology, doesn’t mean that those are the key drivers of that improvement.

    Most organizations continue to report that they are making improvements to their processes and practices internally and methodologically. Lean and Six Sigma process improvement practices continue to be adopted, refined, and pushed through organizations, which leads to greater scrutiny of all business practices, and opportunities to change how work is approached. But because internal practices and methodologies aren’t measurable industry-wide in the same way that total units sold of single-use technologies are, these work practice evolutions tend to be minimized and under-reported, when in reality are the unsung heroes of industry improvement.

    Increasing confidence in analytical testing continues in the industry, and the thinking tends to go that better analytics and higher-precision analytical results leads to better performance, which isn’t necessarily true. In the last two years, however, there has been extraordinarily more focus and work on biosimilars in the industry. The current analytical requirements for biosimilars are generally not stringent enough, and according to many industry experts, perhaps not similar enough to the trial rigor required of the innovator drug to make biosimilars an area of continued large-scale refinement.

    Biotherapeutic developers and CDMOs are tending to see better results than CMOs by refinements in how cell cultures are optimized, and how developability is approached in ways that can harness advancements in risk assessments to increase the likelihood of performance of candidate molecules.

    Technology in pharma and biomanufacturing
    Gartner’s Symposium in Quarter 4, 2016 identified a number of technological platform advances that will in some form permeate many business models, and pharmaceutical manufacturing is no different.

    AI and machine learning. Artificial intelligence (AI) and machine learning involve various levels of deep learning, neural networks, natural language processing (NLP—not to be confused with neurolinguistics programming), and other non-algorithmic-based rule systems. I have used a few of these systems being piloted for clinical trials to help refine designs of trials and ‘learn’ from real-time trial data.

    Intelligent apps. Clearly, there are benefits to apps, which remind patients to, for example, take their medications, or adhere to some other healthcare treatment protocol. But apps that can ‘learn’ continually from ever-changing input data can provide context and suggestions to users when used for more complex applications, such as in the clinical trials oversight as mentioned above.

    Virtual and augmented reality for pharma. Using virtual reality (VR), or augmented reality, for medical training is something that is just beginning to occur in a compelling way. I have used some of these technologies firsthand, and their ability to impact how training and understanding of complex things occurs, is monumental. The major drawback here is that it’s a ‘worst practice’ to simply take content that would have been taught in a lecture or online and force it into three dimensions of VR. Just as there is a ‘right’ modality for certain training applications, VR and AR are particularly suited for complex visuals where 3-D manipulation can help deeper understanding.

    Digital twin. If this is the first place and time you’re hearing of this term and technology, I can guarantee that it won’t be the last! A digital twin is a dynamic model of a physical system that uses data collected by sensors to interpret a sense of its state, develop responses to environmental changes, and improve operations. Top-level digital twins have input from three major sources: metadata of classification and composition; data about current status (temperature, spatial location, time series, mass, velocity); and onboard analytics to develop responses (algorithms and adaptive learning rules for various input levels). Preventive maintenance and instrument/equipment status can be predicted and ‘operationanability maxima’ can be achieved (i.e., as in a design-of-experiments view, there are certain operating ‘maxima’ that give the best possible outputs given a series of inputs).

    Conversational systems. Imagine optical character recognition (OCR) on steroids. OCR is a machine system, which can ‘read’ text, say in printed form, and use it to fill out fields and record data. Conversational systems use ambient meshes to ‘listen’ to discussions and dialogs, and then build machine learning from it. Being able to access cloud or stored data can also allow the conversational system to build sorts-of ‘mind maps’ with hyperlinked data and programs/apps that would link together complex chains of reasoning.

    Mesh app, service architecture, and adaptive security. Unless you’re an expert in IT and security technology, you may have just had your eyes glazed over. But there are some very innovative features here. A mesh app would take many back-end services of a company or organization and link them together—desktop, telephone, smart devices, internal personnel measurement systems, biomanufacturing distributed control systems (DCS), and any other services. It would all be scalable and allow a continuous experience for each user in one place. Of course, the latter part of this section’s title refers to the fact that these deep linkages present huge challenges for digital security. Continuous monitoring of user behavior and system behavior has been deemed a requirement of good security, but also poses Big Brother privacy concerns for most users. This is the antecedent to good platforms and security measures in the Internet of Things (IoT).

    Conclusion
    So the major themes above can be grouped into ‘intelligence everywhere,’ ‘intertwining of the digital and the real,’ and the ‘mesh of platforms.’

    Of course, there’s a tenet in pharma biomanufacturing that the industry lags other high-tech industries by about 20 years. Oftentimes, the reason most cited is that pharma manufacturing is shackled because of regulatory compliance requirements (FDA, EMA, MHRA, etc.), but many of the other competitively advanced industries—aerospace, food and beverage, automotive—are similarly regulated and in some cases to a higher degree.

    What is clear is that we will continue to see an industry in flux, and how we approach biomanufacturing as an industry will depend on many factors, not the least of which includes a new presidential cabinet in the U.S., pressures to reduce drug prices, drug pricing negotiation rules applied between pharma and payers, and a new commissioner at FDA. 

    References
    • BioPlan Associates. (2015). Twelfth annual report and survey of biopharmaceutical manufacturing capacity and production.
    • Zurdo, J., Arnell, A., Obrezanova, O., Smith, N., Gallagher, T., de la Cuesta, R., Locwin, B. (2015). Developability assessment workflows to de-risk biopharmaceutical development. in Kumar, S., & Kumar Singh, S. (eds.). Developability of biotherapeutics: Computational approaches. CRC Press.

    Ben Locwin
    Contributing Editor

    Ben Locwin, PhD, MBA, MS, is a contributing editor to Contract Pharma and the president of Healthcare Science Advisors. He is an expert contact for the American Association of Pharmaceutical Scientists (AAPS), a committee member of the American Statistical Association (ASA), and has been featured by the CDC, the Associated Press, The Wall Street Journal, Forbes, and other media outlets. Follow him at @BenLocwin.
    Related Searches
    • contract manufacturing organizations
    • analytics
    • Pharmaceutical manufacturing
    • it
    Suggested For You
    Ensuring Pharma Manufacturing Quality Ensuring Pharma Manufacturing Quality
    RBQM Comes of Age: COVID as a Catalyst for Change RBQM Comes of Age: COVID as a Catalyst for Change
    Advanced Analytics Advancing Development of Genetic Vaccines Advanced Analytics Advancing Development of Genetic Vaccines
    Outsourcing Solid Dosage Manufacturing Outsourcing Solid Dosage Manufacturing
    Reshaping the Pharmaceutical Supply Chain Reshaping the Pharmaceutical Supply Chain
    Solid Dose Market Trends Solid Dose Market Trends
    Inside a COVID Vaccine Trial Inside a COVID Vaccine Trial
    The Future of Vaccines and Biologics The Future of Vaccines and Biologics
    Parenteral Drug Delivery Trends Parenteral Drug Delivery Trends
    The State of Clinical Trial Technology The State of Clinical Trial Technology
    Advancing Digital Endpoints in Clinical Trials Advancing Digital Endpoints in Clinical Trials
    Mogene Mogene
    CDMOs: Keeping up with Science & Technology CDMOs: Keeping up with Science & Technology
    Contract Pharma Audience Survey Contract Pharma Audience Survey
    Ramping Up COVID-19 Vaccine Fill and Finish Capacity Ramping Up COVID-19 Vaccine Fill and Finish Capacity

    Related Columns

    • Biologics, Proteins, Vaccines | Regulatory Affairs
      What Will Change at FDA for 2021?

      What Will Change at FDA for 2021?

      (R)evolution of the industry’s data, catalyzed by changes at FDA and what’s the likely impact to the pharmaceutical industry?
      Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 04.01.21

    • Biologics, Proteins, Vaccines
      Vaccines and Return-To-Normalcy

      Vaccines and Return-To-Normalcy

      Planning for a future in which COVID-19 won’t simply ‘disappear.’
      Ben Locwin, Contributing Editor 03.01.21

    • Biologics, Proteins, Vaccines
      Vaccines 2021

      Vaccines 2021

      Looking at the behavioral economics of vaccinations.
      Ben Locwin, Contributing Editor 01.27.21


    • Biologics, Proteins, Vaccines
      It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]

      It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]

      Race for the vaccines is heating up.
      Ben Locwin, Contributing Editor 09.09.20

    • Biologics, Proteins, Vaccines
      Outsourcing in China: How far can it go?

      Outsourcing in China: How far can it go?

      China’s biopharmaceutical services market is on pace to top $1 billion by 2021
      Vicky Qing Xia, BioPlan Associates 07.15.19

    • Biologics, Proteins, Vaccines | Drug Development
      The Future Is… Therapeutic

      The Future Is… Therapeutic

      As cell and gene therapies rise, so too does outsourcing
      Ben Locwin 06.13.19


    • Biologics, Proteins, Vaccines
      Innovate UK Grant Supports Viral Vector Manufacturing

      Innovate UK Grant Supports Viral Vector Manufacturing

      Cobra Biologics talks about its recently awarded $3.4 million capital infrastructure investment
      Betsy Louda, Associate Editor 04.10.18

    • Biologics, Proteins, Vaccines | Injectables
      A World of Innovation

      A World of Innovation

      The importance of innovation in the injectable business and the hurdles a CDMO faces
      Claudia Roth, Vetter Pharma-Fertigung GmbH & Co. KG 11.07.17

    • Biologics, Proteins, Vaccines
      India is an Emerging Hub  For Low-cost Vaccines

      India is an Emerging Hub For Low-cost Vaccines

      Improvising basic vaccines to enhance stability, efficacy and compliance
      S. Harachand, Contributing Editor 11.07.17


    • Biologics, Proteins, Vaccines
      Flu Season is Upon Us

      Flu Season is Upon Us

      My chance and capricious Monday afternoon run-in with antiscience nonsense
      Ben Locwin, Contributing Editor 11.07.17

    • Biologics, Proteins, Vaccines
      Trends in New Technologies & Budgets

      Trends in New Technologies & Budgets

      Budget increases in biopharmaceutical industry indicate future growth
      Eric S. Langer, BioPlan Associates 06.06.17

    • Biologics, Proteins, Vaccines
      CMOs Hiring Constraints:  Cell Therapy Manufacturing Expecting Future Challenges

      CMOs Hiring Constraints: Cell Therapy Manufacturing Expecting Future Challenges

      Technically trained staff needed to run complex manufacturing platforms, automation
      Eric S. Langer, BioPlan Associates 03.07.17


    • Biologics, Proteins, Vaccines

      Year-End Trends in Biopharma Contract Manufacturing

      Budgets are flattening, but some CMOs are well positioned for growth
      Eric S. Langer, BioPlan Associates 11.09.16

    • Biologics, Proteins, Vaccines

      Economics of In-House Buffer Preparation

      Evaluating the cost effectiveness of keeping basic ops in-house
      Eric S. Langer, BioPlan Associates 09.08.16

    • Biologics, Proteins, Vaccines | cGMP Manufacture | GMPs/GCPs | Preclinical Outsourcing | Process Development | Risk Management

      Getting to Yes

      The critical attributes CMOs need to demonstrate to win business
      Eric S. Langer, BioPlan Associates 07.14.15

    Trending
    • Jubilant, Novavax Enter COVID-19 Vaccine Partnership
    • Pfizer, BioNTech Expand COVID-19 Vaccine Agreement With EU
    • Resilience Acquires Ology Bioservices
    • Ensuring Pharma Manufacturing Quality
    • Sartorius Expands In The UK
    Breaking News
    • Resilience Acquires Ology Bioservices
    • RDIF, Hualan Ink COVID-19 Vaccine Deal
    • Kintor, Visum Enter COVID-19 Manufacturing Partnership
    • Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU
    • Evotec Enters Master Service Agreement with Kazia Therapeutics
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Review Concludes That Refined Grains Have a Place in Healthy Eating Patterns
    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    SOS '21 Call For Papers
    ICP Acquiring Choice Adhesives
    PPG Brand Olympic Stains Announces 1st Ever 2021 Stain Color of the Year
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Canon Medical's One-Beat Spectral Cardiac CT
    NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite
    IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Resilience Acquires Ology Bioservices
    RDIF, Hualan Ink COVID-19 Vaccine Deal
    Kintor, Visum Enter COVID-19 Manufacturing Partnership
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    2021 Perfumed Plume Awards Announces Finalists
    Bésame Cosmetics Unveils Marilyn Monroe Collection
    Procos Opens U.S. Office
    Happi

    Latest Breaking News From Happi

    Hair Luxury Company Expands Availability of Its Vegan Beauty to Walmart Online
    ACI Appoints Director, State Government Affairs
    Jergens Launches Mother’s Day Campaign
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Sakata INX and INX International continue sustainability efforts
    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Andritz to Supply Elliptical Cylinder Pre-Needler in France
    Ahlstrom-Munksjö to be Delisted from Nasdaq Stockholm
    Radienz Living Introduces Sustainable Products
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AgNovos Healthcare's AGN1 LOEP SV Kit Obtains IDE
    First Surgeries Completed with Globus Medical's CREO ONE Robotic Screw
    BioMagnetic Sciences Names President and CEO
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI, Center for Automotive Research Collaborate
    Zebra Technologies Introduces New Alliance Track for PartnerConnect Channel Program
    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login